Householder Group Estate & Retirement Specialist’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$2K Sell
50
-824
-94% -$39.4K ﹤0.01% 484
2024
Q3
$58K Buy
874
+100
+13% +$9.18K 0.02% 458
2024
Q2
$91K Sell
774
-213
-22% -$27K 0.03% 372
2024
Q1
$105K Hold
987
0.03% 336
2023
Q4
$98K Buy
987
+200
+25% +$16.8K 0.03% 341
2023
Q3
$81.3K Buy
+787
New +$87.8K 0.03% 359
2023
Q1
$119K Buy
777
+397
+104% +$65.5K 0.05% 267
2022
Q4
$68K Hold
380
0.1% 100
2022
Q3
$44K Buy
+380
New +$57.7K 0.02% 423

Other funds holding MRNA

Householder Group Estate & Retirement Specialist's MRNA Position: Q4 2024 in Review

Householder Group Estate & Retirement Specialist reduced its Moderna (MRNA) stake by 94% in Q4 2024, selling an estimated $39.4K and leaving 50 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #484.

Householder Group Estate & Retirement Specialist first reported a position in MRNA in Q3 2022 and has held it in 9 quarters since. The position peaked at $119K in Q1 2023. 746 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Householder Group Estate & Retirement Specialist held 50 shares of Moderna worth $2K as of Q4 2024.
  • Householder Group Estate & Retirement Specialist sold 824 Moderna shares in Q4 2024, an estimated $39.4K.
  • Moderna made up ﹤0.01% of Householder Group Estate & Retirement Specialist's portfolio in Q4 2024, its #484 holding.
  • Householder Group Estate & Retirement Specialist first reported a position in Moderna in Q3 2022 and has held it in 9 quarters since.
  • Householder Group Estate & Retirement Specialist's Moderna position peaked at $119K in Q1 2023.
  • 746 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2024, filed 15 Jan 2025.